Prokidney (PROK) Operating Leases (2021 - 2026)
Prokidney (PROK) reported Operating Leases of $2.7 million for Q1 2026, up 6.49% year-over-year from $2.5 million in Q1 2025, and down 9.78% quarter-over-quarter from $3.0 million in Q4 2025.
Prokidney (PROK) Operating Leases (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Operating Leases data on file, last reported at $2.7 million in Q1 2026.
- Operating Leases for Q1 2026 came in at $2.7 million, up 6.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 6.49% YoY), and the FY2025 annual result was $3.0 million, up 19.99% from the prior year.
- Operating Leases fell to $2.7 million in Q1 2026 per PROK's latest filing, from $3.0 million in the prior quarter.
- Over five years, Operating Leases peaked at $5.6 million in Q2 2024 and troughed at $1.7 million in Q3 2022.
- A 5-year average of $3.2 million and a median of $2.7 million in 2026 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases surged 154.72% in 2024, then sank 48.3% in 2025.
- A 5-year view of Operating Leases shows it stood at $1.9 million in 2022, then surged by 89.4% to $3.6 million in 2023, then slumped by 31.55% to $2.5 million in 2024, then gained by 19.99% to $3.0 million in 2025, then retreated by 9.78% to $2.7 million in 2026.
- Business Quant data shows PROK's Operating Leases at $2.7 million in Q1 2026, $3.0 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 3.61 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Dec 31, 2021 | 1.07 Mn |